| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |